首页> 外文期刊>Microbial Cell Factories >High yield expression of an AHL-lactonase from Bacillus sp. B546 in Pichia pastoris and its application to reduce Aeromonas hydrophila mortality in aquaculture
【24h】

High yield expression of an AHL-lactonase from Bacillus sp. B546 in Pichia pastoris and its application to reduce Aeromonas hydrophila mortality in aquaculture

机译:来自芽孢杆菌的AHL-内酰胺酶的高产量表达。毕赤酵母中的B546及其在降低水产养殖中嗜水气单胞菌死亡率中的应用

获取原文
           

摘要

Background Aeromonas hydrophila is a serious pathogen and can cause hemorrhagic septicemia in fish. To control this disease, antibiotics and chemicals are widely used which can consequently result in "superbugs" and chemical accumulation in the food chain. Though vaccine against A. hydrophila is available, its use is limited due to multiple serotypes of this pathogen and problems of safety and efficacy. Another problem with vaccination is the ability to apply it to small fish especially in high numbers. In this study, we tried a new way to attenuate the A. hydrophila infection by using a quorum quenching strategy with a recombinant AHL-lactonase expressed in Pichia pastoris . Results The AHL-lactonase (AiiAB546) from Bacillus sp. B546 was produced extracellularly in P. pastoris with a yield of 3,558.4 ± 81.3 U/mL in a 3.7-L fermenter when using 3-oxo-C8-HSL as the substrate. After purification with a HiTrap Q Sepharose column, the recombinant homogenous protein showed a band of 33.6 kDa on SDS-PAGE, higher than the calculated molecular mass (28.14 kDa). Deglycosylation of AiiAB546 with Endo H confirmed the occurrence of N -glycosylation. The purified recombinant AiiAB546 showed optimal activity at pH 8.0 and 20°C, exhibited excellent stability at pH 8.0-12.0 and thermal stability at 70°C, was firstly confirmed to be significantly protease-resistant, and had wide substrate specificity. In application test, when co-injected with A. hydrophila in common carp, recombinant AiiAB546 decreased the mortality rate and delayed the mortality time of fish. Conclusions Our results not only indicate the possibility of mass-production of AHL-lactonase at low cost, but also open up a promising foreground of application of AHL-lactonase in fish to control A. hydrophila disease by regulating its virulence. To our knowledge, this is the first report on heterologous expression of AHL-lactonase in P. pastoris and attenuating A. hydrophila virulence by co-injection with AHL-lactonase.
机译:背景嗜水气单胞菌是一种严重的病原体,可导致鱼类出血性败血病。为了控制这种疾病,广泛使用了抗生素和化学药品,这些抗生素和化学药品可能导致食物链中的“超级细菌”和化学物质积聚。尽管可获得抗亲水性链球菌疫苗,但由于该病原体的多种血清型以及安全性和有效性问题,其使用受到限制。疫苗接种的另一个问题是能否将其应用于小鱼,尤其是数量较大的鱼。在这项研究中,我们尝试了一种新方法,通过使用定点猝灭策略和巴斯德毕赤酵母中表达的重组AHL-内酰胺酶来减轻嗜水链球菌的感染。结果芽孢杆菌的AHL-内酰胺酶(AiiA B546 )。当使用3-oxo-C8-HSL作为底物时,在3.7 L发酵罐中,巴斯德毕赤酵母细胞外产生B546,产量为3,558.4±81.3 U / mL。用HiTrap Q Sepharose色谱柱纯化后,重组同质蛋白在SDS-PAGE上显示33.6 kDa的条带,高于计算的分子量(28.14 kDa)。 AiiA B546 与Endo H的去糖基化反应证实了N-糖基化的发生。纯化的重组AiiA B546 在pH 8.0和20°C时表现出最佳活性,在pH 8.0-12.0时表现出优异的稳定性,在70°C时表现出热稳定性,首先被证实具有明显的蛋白酶抗性,并且具有广泛的底物特异性。在应用试验中,重组AiiA B546 与普通鲤鱼同时注射亲水性链球菌降低了死亡率,延缓了鱼类的死亡时间。结论我们的结果不仅表明低成本生产AHL-内酰胺酶的可能性,而且为通过调节AHL-内酰胺酶的毒力控制鱼类的亲水性开辟了广阔的前景。据我们所知,这是关于AHL-内酰胺酶在巴斯德毕赤酵母中异源表达和通过与AHL-内酰胺酶共同注射来减轻亲水性链球菌致病性的首次报道。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号